Cargando…
Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
Hypoimmunogenic human pluripotent stem cells (hPSCs) are expected to serve as an unlimited cell source for generating universally compatible “off-the-shelf” cell grafts. However, whether the engineered hypoimmunogenic hPSCs still preserve their advantages of unlimited self-renewal and multilineage d...
Autores principales: | Chen, Yifan, Zhou, Yanjie, Zhou, Zhongshu, Fang, Yujiang, Ma, Lin, Zhang, Xiaoqing, Xiong, Jie, Liu, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872349/ https://www.ncbi.nlm.nih.gov/pubmed/36691086 http://dx.doi.org/10.1186/s13287-022-03233-z |
Ejemplares similares
-
Generation of universal and hypoimmunogenic human pluripotent stem cells
por: Ye, Qingsong, et al.
Publicado: (2020) -
Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells
por: Zhao, Wei, et al.
Publicado: (2020) -
Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine
por: Trionfini, Piera, et al.
Publicado: (2023) -
Is hypoimmunogenic stem cell therapy safe in times of pandemics?
por: Matheus, Friederike, et al.
Publicado: (2022) -
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application
por: Kitano, Yuko, et al.
Publicado: (2022)